International Biotechnology Trust plcHere is the public summary page for International Biotechnology Trust plc. Please login to see the complete information for International Biotechnology Trust plc including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how International Biotechnology Trust plc stacks up relative to its peers. |
| Darwin Score | +2 |
| Ticker | IBT |
| Latest Price | 6.42 GBX as of close on 25-Jul-2025 |
| 3 Month price range | 5.36 to 6.42 GBX |
| Market Capitalisation | 219.37Mn GBX |
| Country | UK |
| Region | Europe |
| Economic Sector | Financials |
| Business Sector | Financial Services |
| Industry | Capital Markets |
| Sub-Industry | Asset Management & Custody Banks |
| Description | International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company's assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of the See More ... |
| Company URL | https://www.internationalbiotrust.com |
| See Darwins Full Analysis for International Biotechnology Trust plc |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for International Biotechnology Trust plc. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +7 |
| Sentiment | News and Candle Patterns. | -1 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | 0 |
| Flow | Institutional, Fund and Insider buying and selling. | 0 |
| Models | Forecast models. | -4 |
Alerts
There are 3 live alerts for International Biotechnology Trust plc. All the alerts are negative.
- Overbought - The 5 week RSI is +80.9. (Negative)
- Candle Pattern :: Inverted Hammer (Bearish) (Negative) (Negative)
- Divergence: Px Up & 5d RSI Down last 10 days. This alert has occurred 42 times over the last last year. The average forward returns are -1.5% over 5 days, -1.2% over 10 days, -0.9% over 15 days and -0.7% over 20 days. (Negative)
Peer Comparison
There are 111 peers of International Biotechnology Trust plc.
Share 
